Details for New Drug Application (NDA): 062716
NDA 062716 describes VANCOCIN HYDROCHLORIDE, which is a drug marketed by Ani Pharms and Steriscience and is included in six NDAs. It is available from four suppliers. Additional details are available on the VANCOCIN HYDROCHLORIDE profile page.
The generic ingredient in VANCOCIN HYDROCHLORIDE is vancomycin hydrochloride. There is one drug master file entry for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.
The generic ingredient in VANCOCIN HYDROCHLORIDE is vancomycin hydrochloride. There is one drug master file entry for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.
Summary for 062716
| Tradename: | VANCOCIN HYDROCHLORIDE |
| Applicant: | Steriscience |
| Ingredient: | vancomycin hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062716
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
| Approval Date: | Mar 13, 1987 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Mar 13, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
